FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,872 letters match. Newest first.

  1. Analytical Food Laboratories, Inc.

    FDA warned contract testing lab Analytical Food Laboratories after inspection found unvalidated drug test methods and weak quality oversight.

    High risk
  2. Top Health Manufacturing, LLC

    Top Health Manufacturing's dietary supplements violated manufacturing and labeling rules, FDA says.

    Medium
  3. Argon Medical Productions & Vertrieb Gesellschaft MBH & CO

    FDA warns Argon Medical over dental implant quality-system failures, unreported injuries, and missing unique device identifier labeling.

    High risk
  4. MedOffice Saglik Endustri Anonim Sirketi

    FDA warned MedOffice Saglik after an inspection found missing batch release testing and inadequate process validation for over-the-counter drugs.

    High risk
  5. Choice All Natural, Inc. dba Om Botanical

    FDA warns Om Botanical of Apex, NC over filthy manufacturing, an unapproved rash cream, and lapsed FDA registration.

    High risk
  6. Future Best Trading Inc.

    FDA found Listeria in imported enoki mushrooms and cited Future Best Trading for lacking required supplier verification records.

    High risk
  7. Paso Real Produce LLC

    Paso Real Produce, a Texas importer, had no Foreign Supplier Verification Program at all for its imported avocados and limes — a repeat finding.

    Medium
  8. Diora Kimya Sanayi ve Ticaret Limited Sirketi

    FDA cited Diora Kimya for drug manufacturing quality failures and for an unlisted antibacterial soap.

    High risk
  9. Blackfly Investments, LLC dba Molecular® Testing Labs

    Blackfly Investments dba Molecular Testing Labs sells an HIV dried blood spot self-collection kit without FDA marketing authorization.

    High risk
  10. Soliteint Kozmetikai KFT

    Hungarian contract maker Soliteint Kozmetikai failed to test OTC pain-relief drugs and ingredients, FDA says; U.S. production halted.

    High risk
  11. Namita A. Goyal, M.D.

    FDA warned clinical investigator Dr. Namita Goyal over a biologic trial that enrolled ineligible subjects and kept poor records.

    High risk
  12. Omni Lens Pvt. Ltd.

    FDA warns Omni Lens about CGMP failures and misbranding of ophthalmic OTC drugs made by unregistered contract manufacturers.

    High risk
  13. Pinnacle Transplant Technologies, LLC

    FDA warns Pinnacle Transplant Technologies over unapproved injectable amniotic products and sterility CGMP failures.

    High risk
  14. Amnio Technology, LLC

    FDA warned Amnio Technology over unapproved injectable amniotic products and serious manufacturing deviations at its Phoenix facility.

    High risk
  15. Stokes Healthcare Inc. dba Epicur Pharma

    Sterile compounding facility Epicur Pharma made drugs under insanitary conditions and with serious quality failures, FDA says.

    High risk
  16. Hemarus LLC

    Hemarus LLC failed blood-product manufacturing rules, including unapproved donor reinstatement and records signed when physician absent.

    High risk
  17. Bacalao Giraldo, S.L.U.

    FDA warns Spain's Bacalao Giraldo over inadequate HACCP controls for Clostridium botulinum in refrigerated and frozen desalted cod.

    High risk
  18. Bernardo Farms, LLC

    FDA: Bernardo Farms papaya farm in Pahoa, Hawaii, held papayas under insanitary conditions, with no field toilets and dirty tools.

    High risk
  19. Outin Futures Corp.

    FDA warned Outin Futures, a Korean drug manufacturer, of CGMP violations and sunscreen misbranding after a March 2024 inspection.

    High risk
  20. Ya Ya Foods USA, LLC

    FDA warned Ya Ya Foods USA that its aseptic oat milk made in Ogden, Utah, was adulterated after an inspection found processing deviations.

    High risk
  21. Alfred Louie, Inc.

    Alfred Louie, Inc. lacked allergen, mycotoxin and metal controls for fresh noodles and mislabeled wheat, FDA says.

    High risk
  22. Procesadora Marina De La Costa Oriental Del Lago C.A.

    FDA found HACCP violations at Procesadora Marina, a Venezuelan crabmeat processor; RTE crab may be unsafe.

    High risk
  23. Mexicanrxpharm.com

    FDA told Mexicanrxpharm.com to stop selling unapproved, misbranded opioid pain drugs to U.S. consumers online.

    High risk
  24. Louisiana State University Health Science Center IRB

    FDA warns Louisiana State University Health Science Center IRB about missed continuing reviews and unreported study terminations for drug research.

    Medium
  25. MMC Healthcare Ltd.

    FDA warned MMC Healthcare Ltd. in Chennai that its drug products violate manufacturing rules, citing backdated records, weak computer controls, and unvalidated test methods.

    High risk
  26. Green Day Produce, Inc.

    FDA found Green Day Produce lacked adequate import safety checks for mushrooms and mangos.

    Medium
  27. JC Finest Produce Inc

    FDA warns JC Finest Produce for lacking a foreign supplier verification program for imported Persian limes, rambutan, and Thai bananas.

    Medium
  28. Makra Kozmetika D.O.O.

    FDA warns Makra Kozmetika over OTC drug manufacturing violations, including missing batch and ingredient testing, after April 2024 inspection.

    High risk
  29. Ice Cream House LLC

    Ice Cream House LLC's Brooklyn ice cream plant held a resident Listeria strain tied to a 2023 outbreak, FDA says.

    High risk
  30. Far East Summit LLC

    FDA says Far East Summit sold herbal supplements as unapproved drugs and made them under serious manufacturing violations.

    High risk
  31. Pacific Exchange Distributors LLC

    FDA warns importer Pacific Exchange Distributors it lacked a foreign supplier verification program for most imported foods.

    High risk
  32. JJH Trading Inc.

    FDA warned importer JJH Trading Inc. of El Monte, California, that it had no supplier verification program for any food it imports.

    Medium
  33. Diamond Chemical Co., Inc.

    Diamond Chemical Co. in East Rutherford, NJ, made OTC hand sanitizers without required ingredient and finished-product testing or process validation.

    High risk
  34. Clean Solutions LLC

    FDA warned Clean Solutions LLC that its OTC hand soaps and sanitizer were adulterated because it released drugs without component or finished-product testing.

    High risk
  35. Troya Del Campo USA LLC

    Troya Del Campo USA lacked a Foreign Supplier Verification Program (FSVP) for all fresh produce it imports, including avocado, cilantro, broccoli and mango.

    Medium
  36. NRS Enterprises, Inc. d/b/a Sunflour Bakery

    FDA found Sunflour Bakery's ready-to-eat baked goods made under insanitary conditions, with allergen, pest, and food-safety-plan failures.

    High risk
  37. Azurity Pharmaceuticals, Inc.

    FDA warned Azurity Pharmaceuticals over unapproved FIRST drug kits and manufacturing quality failures at its Wilmington, MA plant.

    High risk
  38. Accupack Midwest, Inc.

    Accupack Midwest, an over-the-counter drug contract manufacturer, lacked adequate water controls and process validation.

    High risk
  39. Restorative Botanicals, LLC

    FDA warns Restorative Botanicals over CGMP failures for two mushroom dietary supplements, including missing identity and toxic-element limits.

    Medium
  40. Wittman Pharma, Inc.

    FDA warns Wittman Pharma, an OTC drug maker in Brooksville, Florida, that weak quality oversight and contaminated water make its products adulterated.

    High risk
  41. Warbucks Seafood NY LLC

    Brooklyn importer Warbucks Seafood NY had no FSVP for truffles, vanilla pods and truffle-flavored olive oil, FDA found.

    Medium
  42. Aerosol and Liquid Packaging, Inc.

    FDA warns Aerosol and Liquid Packaging on CGMP failures and unapproved antiseptic spray claims.

    High risk
  43. Brewing Market Coffee

    FDA warns Brewing Market Coffee that its acidified chai teas are adulterated because required scheduled processes and acidified-food controls were missing.

    High risk
  44. Aromas Para El Alma S.A.

    Aromas Para El Alma, a Costa Rica drug manufacturer, made EREWHON hand sanitizer/spray subpotent and broke manufacturing rules.

    High risk
  45. EnviroServe Chemicals & Cleaners Ltd.

    EnviroServe's SOPURE hand sanitizer had manufacturing-quality violations and was sold as an unapproved, misleadingly labeled drug.

    High risk
  46. Greco Gas, Inc.

    Greco Gas, Inc. released medical gases without identity or purity testing and without quality oversight.

    High risk
  47. St. Louis Calco, LLC

    FDA warned St. Louis Calco, a Missouri sprout operation, that mung bean and soybean sprouts were held under insanitary conditions.

    High risk
  48. Mid-Link Testing Company, Ltd

    FDA warns Mid-Link Testing over unreliable Good Laboratory Practice (GLP) safety data for medical device tests.

    High risk
  49. Sanitation & Environmental Technology Institute dba SDWH

    FDA found GLP violations in SDWH's nonclinical testing of medical devices, raising doubts about safety data.

    High risk
  50. Avaria Health & Beauty Corp.

    FDA warns Canadian maker Avaria Health & Beauty over CGMP failures in OTC drug products, including skipped ingredient identity testing.

    High risk